Baxalta

ADYNOVATE - Cost

Last Updated: April 1st, 2024

HCPCS:

J7207

HCPCS Code Descriptor:

Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.

Medicare Payment Limit:

The ADYNOVATE Medicare Payment Limit is $2.053

Average Sale Price:

ADYNOVATE ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The ADYNOVATE Medicare Co-insurance percentage is 20%. ADYNOVATE's Medicare Co-insurance amount is $0.41 per HCPCS unit.

APC Code:

The Adynovate APC Code is: 1844

APC Payment Limit:

The APC Payment Limit for ADYNOVATE is available. Login to view.

Adynovate Cost Information:

ADYNOVATE, a product of Baxalta, became effective on January 1, 2017, and is aligned to HCPCS J7207. ADYNOVATE has seven NDCs mapped to J7207 without issue. Pricing has stayed somewhat constant between 2022 and 2024. WAC and AWP had moderate increases of almost 15% in 2023 and a minimal increase of around 5% at the beginning of 2024.

ACCESS PRICING AND MORE BY REGISTERING

Adynovate’s wholesale acquisition cost (WAC) information was last updated on:
January 1, 2024
Adynovate’s average wholesale price (AWP) information was last updated on:
January 1, 2024